Recent studies show that the ERK5 inhibitor XMD8-92 significantly impairs macrophage clearance of apoptotic tumor cells, leading to a higher conversion of apoptotic cells to necroptosis and the release of TAAs. The gene discussed is MAPK7; the disease is neoplasm.